Literature DB >> 27644446

Treatment of high blood pressure in elderly and octogenarians: European Society of Hypertension statement on blood pressure targets.

Sverre E Kjeldsen1,2, Aud Stenehjem1, Ingrid Os1,2, Philippe Van de Borne3, Michel Burnier4, Krzysztof Narkiewicz5, Josep Redon6, Enrico Agabiti Rosei7, Giuseppe Mancia8.   

Abstract

The European Society of Hypertension recommend the following main rules for treatment of hypertension in elderly and octogenarians: 1) In elderly hypertensives with SBP ≥ 160 mmHg there is solid evidence to recommend reducing SBP to between 140 mmHg and 150 mmHg. 2) In fit elderly patients less than 80 years old treatment may be considered at SBP ≥ 140 mmHg with a target SBP < 140 mmHg if treatment is well tolerated. 3) In fit individuals older than 80 years with an initial SBP ≥ 160 mmHg it is recommended to reduce SBP to between 150 mmHg and 140 mmHg. 4) In frail elderly patients, it is recommended to base treatment decisions on comorbidity and carefully monitor the effects of treatment. 5) Continuation of well-tolerated antihypertensive treatment should be considered when a treated individual becomes octogenarian. 6) All hypertensive agents are recommended and can be used in the elderly, although diuretics and calcium antagonists may be preferred in isolated systolic hypertension.

Entities:  

Keywords:  Blood pressure-lowering treatment; European Society of Hypertension; blood pressure targets; elderly patients; octogenarians

Mesh:

Year:  2016        PMID: 27644446     DOI: 10.1080/08037051.2016.1236329

Source DB:  PubMed          Journal:  Blood Press        ISSN: 0803-7051            Impact factor:   2.835


  9 in total

1.  Change in Prescribing for Secondary Prevention of Stroke and Coronary Heart Disease in Finnish Nursing Homes and Assisted Living Facilities.

Authors:  Natali Jokanovic; Hannu Kautiainen; J Simon Bell; Edwin C K Tan; Kaisu H Pitkälä
Journal:  Drugs Aging       Date:  2019-06       Impact factor: 3.923

Review 2.  Hypertension Management at Older Age: An Update.

Authors:  Rita Del Pinto; Claudio Ferri
Journal:  High Blood Press Cardiovasc Prev       Date:  2018-11-22

Review 3.  Management of Hypertension in the Elderly and Frail Elderly.

Authors:  Claudio Ferri; Livia Ferri; Giovambattista Desideri
Journal:  High Blood Press Cardiovasc Prev       Date:  2017-02-08

4.  Antihypertensive Treatment Patterns and Blood Pressure Control in Older Adults: Results from the Berlin Aging Study II.

Authors:  Maximilian König; Maik Gollasch; Adrian Rosada; Ilja Demuth; Dominik Spira; Elisabeth Steinhagen-Thiessen
Journal:  Drugs Aging       Date:  2018-11       Impact factor: 3.923

5.  Time in Target Range for Systolic Blood Pressure and Cardiovascular Outcomes in Patients With Heart Failure With Preserved Ejection Fraction.

Authors:  Rihua Huang; Yifen Lin; Menghui Liu; Zhenyu Xiong; Shaozhao Zhang; Xiangbin Zhong; Xiaomin Ye; Yiquan Huang; Xiaodong Zhuang; Xinxue Liao
Journal:  J Am Heart Assoc       Date:  2022-03-15       Impact factor: 6.106

6.  What Is the Ideal Blood Pressure Threshold for the Prevention of Atrial Fibrillation in Elderly General Population?

Authors:  Yoon Jung Park; Pil-Sung Yang; Hee Tae Yu; Tae-Hoon Kim; Eunsun Jang; Jae-Sun Uhm; Hui-Nam Pak; Moon-Hyoung Lee; Gregory Y H Lip; Boyoung Joung
Journal:  J Clin Med       Date:  2020-09-16       Impact factor: 4.241

7.  Post-stroke Anxiety Analysis via Machine Learning Methods.

Authors:  Jirui Wang; Defeng Zhao; Meiqing Lin; Xinyu Huang; Xiuli Shang
Journal:  Front Aging Neurosci       Date:  2021-06-25       Impact factor: 5.750

8.  Prevalence and treatment of diabetes mellitus and hypertension among older adults with intellectual disability in comparison with the general population.

Authors:  Anna Axmon; Gerd Ahlström; Peter Höglund
Journal:  BMC Geriatr       Date:  2017-11-23       Impact factor: 3.921

9.  Exploratory study on the safety and effectiveness of Yizhi Qingxin Decoction (capsules) in the treatment of hypertension in the elderly with mild cognitive impairment (deficiency of kidney essence syndrome).

Authors:  Bi-Qing Wang; Jun Mei; Lu Liu; Chun-Xiao Ju; Jun-Nan Zhao; Ping Zhang; Feng-Qin Xu; Ke-Ji Chen
Journal:  Medicine (Baltimore)       Date:  2020-07-02       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.